#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Meningitis meningococcal Fibrosarcoma Metastases to peritoneum Acute lymphocytic leukaemia recurrent Cytomegalovirus infection Toxic epidermal necrolysis Oesophageal adenocarcinoma Urea cycle disorder Pulmonary hypertension Staphylococcal infection Ocular myasthenia Congenital nephrogenic diabetes insipidus Leukodystrophy Acute leukaemia Herpes simplex More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Basic Information Vascular malformation – Treatment Haemophilia B with anti factor IX – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Primary biliary cholangitis – Treatment Cholangitis sclerosing – Treatment Hereditary neuropathic amyloidosis – Treatment Loeys-Dietz syndrome – Diagnostics Carcinoid syndrome – Diagnostics Alternating hemiplegia of childhood – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Disodium Levofolinate Treprostinil Sodium Psma-11 Pembrolizumab M1P Dipotassium Salt Rezvilutamide Pegipanermin Ripretinib Evolocumab Teclistamab Risperidone Avutometinib Netupitant Cobolimab Tusamitamab Ravtansine Abemaciclib SGN-ALPV Bms-986435 Phleum Pratense (225) Azd0901 More therapies…

    Learn about Your Condition

    Mast cell activation syndrome Deafness Venous thrombosis limb Decreased appetite Device related infection Diabetic foot Lymphoedema Hypoalbuminaemia Papillary thyroid cancer Open angle glaucoma Squamous cell carcinoma Carotid artery stenosis Microvillous inclusion disease Vertebrobasilar stroke Premature rupture of membranes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on the Effects of 30% vs. 60% Oxygen Levels at Birth for Improving Development in Premature Infants

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Premature baby
    Investigated Drugs:
    • Oxygen Ph.eur.
    Ireland

  • Study on the Safety and Effects of Tolvaptan for Children with Autosomal Recessive Polycystic Kidney Disease (ARPKD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Tolvaptan
    Belgium Germany Poland Spain

  • Long-term Safety Study of Exagamglogene Autotemcel for Patients with Sickle Cell Disease or Transfusion-Dependent Thalassemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Thalassaemia
    Investigated Drugs:
    • Exagamglogene Autotemcel
    Belgium Germany Italy

  • Study on ER004 for Treating Boys with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Congenital ectodermal dysplasia
    Investigated Drugs:
    • Human Immunoglobulin G1 Constant Region – Human Ectodysplasin-A1 Receptor-Binding Domain Fusion Protein
    France Germany Italy Spain

  • Study on Enalapril for Adults with Painful Venous Malformations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriovenous malformation
    Investigated Drugs:
    • Enalapril Maleate
    Norway

  • Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections

    Recruiting

    3 1
    Investigated Drugs:
    • Mavorixafor
    Belgium Czechia France Germany Greece Hungary +6
Previous Page
1 … 12 13 14 15 16 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!